Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Electromed, Inc.ELMD · Entity 1958 | Chief Commercial Officer | July 01, 2022 | July 06, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Electromed, Inc.
Report date July 01, 2022 · Filed July 06, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,900 |
Reported balance
After 2022-07-01 transaction · row 1
1 source rowRow 1 · 2022-07-01 · Grant · Acquired 7,400 · Balance 12,900 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.90 · Expires 2032-06-30 | Direct | 8,800 |
Reported balance
After 2022-07-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-07-01 · Grant · Acquired 8,800 · Balance 8,800 F1: Stock options scheduled to vest in substantially equal increments on each of June 30, 2023, 2024 and 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock options scheduled to vest in substantially equal increments on each of June 30, 2023, 2024 and 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2022 Filed Jul 6, 2022 23:50 UTC | Electromed, Inc. ELMD · Entity 1958 | GrantEmployee Stock Option (right to buy) · Derivative | 8,800 | $0.00 Strike: $9.90 | $0.00 |
DisclosureSEC source: 0001437749-22-016760 · rdgdoc.xml · derivative · entry 2 Holland Christopher G. · CIK 0001913383 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,800 Underlying: Common Stock · 8,800 shares Expires 2032-06-30 F1 · derivative.exercise_date: Stock options scheduled to vest in substantially equal increments on each of June 30, 2023, 2024 and 2025. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 23:50 UTC | Electromed, Inc. ELMD · Entity 1958 | GrantCommon Stock | 7,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-016760 · rdgdoc.xml · nonDerivative · entry 1 Holland Christopher G. · CIK 0001913383 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,900 Read SEC document |
| February 16, 2022 Filed Feb 25, 2022 14:59 UTC | Electromed, Inc. ELMD · Entity 1958 | GrantEmployee Stock Option (right to buy) · Derivative | 7,200 | $0.00 Strike: $12.11 | $0.00 |
DisclosureSEC source: 0001437749-22-004401 · rdgdoc.xml · derivative · entry 2 Holland Christopher G. · CIK 0001913383 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,200 Underlying: Common Stock · 7,200 shares Expires 2032-02-15 F1 · derivative.exercise_date: Stock option vests in equal increments on each of February 15, 2023, 2024 and 2025. Read SEC document |
| February 16, 2022 Filed Feb 25, 2022 14:59 UTC | Electromed, Inc. ELMD · Entity 1958 | GrantCommon Stock | 5,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004401 · rdgdoc.xml · nonDerivative · entry 1 Holland Christopher G. · CIK 0001913383 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.